Induction of Antitumor Immunity via Enhanced Antigen Presentation (None)

This strategy involves enhancing the presentation of antigens on tumor cells to improve their recognition and destruction by the immune system. It is a cornerstone of cancer immunotherapy, aiming to increase the effectiveness of treatments like checkpoint inhibitors.\n\nThis approach leverages various mechanisms to boost the immune response against cancer cells. Key components include the major histocompatibility complex class I (MHC I) pathway, which is crucial for presenting antigens to CD8+ T cells. Tumors often evade this pathway by reducing MHC I expression, among other strategies. Techniques to enhance antigen presentation involve modulating the tumor microenvironment, using adjuvants, and targeting specific pathways like the interferon (IFN) pathway to upregulate MHC I and other components of the antigen presentation machinery[1][2][3].

Other names

Antigen Presentation EnhancementImmunotherapy for Cancer

Enhancing recognition of tumor cells by the immune system; Increasing the expression of antigens on tumor cells